Abstract:Abstract Background/Aims Respiratory involvement specifically interstitial lung disease (ILD) is a recognised complication of mixed connective tissue disease (MCTD), with a reported prevalence ranging from 40-78%. Surveillance for ILD in other connective tissue diseases such as systemic sclerosis is established clinical practice. Using guidelines recently published by the American College of Rheumatology (2023) we undertook a service evaluation to evaluate current practice for patients in our centre. Methods Electronic case notes were searched using key terms ‘mixed connective tissue disease’, ‘MCTD’ and ‘anti-RNP positive’ to identify patients seen between January 2021-2023. Patients identified were then compared against three MCTD classification criteria (Sharp et al, Alarcon-Sergovia et al and Kasukawa et al). To ensure a robust diagnosis, only those meeting the classification threshold on two or more criterion were included. Results 56 patients were identified however only 44 met two classification criteria and were subsequently included. Mean age was 47.3 years with 40/44 (91%) female. 28/44 (64%) had previous CT chest imaging. In the remaining 16/44 (46%), none had reported symptoms suggestive of ILD in preceding two years. 34/44 (77%) patients had previous pulmonary function testing. In those without, 1/10 had recently reported dyspnoea. 9/44 (20%) had identified MCTD-ILD of which 7/9 (30%) were on immunosuppression, 3/9 for predominant lung disease. Of those with ILD, 7/9 (78%) had had PFTs in the last year. No patients with ILD had undergone assessment for ambulatory desaturation. 7/9 (78%) patients with ILD had received specialist respiratory input, 1 had been seen in a general respiratory clinic, and in 1 case it was unknown. All patients with identified ILD who met established criteria for treatment were receiving immunosuppression. No patient met criteria for progressive fibrotic ILD. No specific disease characteristics (utilising clinical criterion from classification criteria) were demonstrated to have association with ILD (statistical analysis performed using the chi-squared test). No association was demonstrated in patients displaying anti- Ro52 and Ro60 positivity and ILD. Conclusion This evaluation has highlighted that patients with identified MCTD-ILD are being treated and monitored well. However further surveillance for pulmonary involvement both at baseline and then subsequent interval pulmonary function testing needs to improve. This may account for the lower prevalence of ILD in our MCTD cohort in comparison to the literature. Surveillance of pulmonary involvement should take place regardless of clinical disease manifestations displayed. We need to establish feasibility for ambulatory desaturation testing in those with ILD within our outpatient setting. With increasing immunomodulatory treatment available identifying patients with MCTD-ILD is imperative. Disclosure R. Benson: None. K. Mashida: None. M. Ahmad: None. L.G. Spencer: None. Z. McLaren: None. T. Barnes: None.

BPF-GILD study: an observational cohort study of UK pigeon fanciers

Does a Type of Inciting Antigen Correlate with the Presence of Lung Fibrosis in Patients with Hypersensitivity Pneumonitis?

Unabated occupational risk in a patient with rheumatoid pulmonary fibrosis

Clinical Features of Hypersensitivity Pneumonitis in Children: A Single Center Study

Clinical, Radiological and Pathological Insights into Hypersensitivity Pneumonitis

Clinical Characteristics and Outcomes of Hypersensitivity Pneumonitis: a Population-Based Study in China

Clinical characteristics of hypersensitivity pneumonitis: non-fibrotic and fibrotic subtypes

Clinical Characteristic Analysis of 96 Cases of Hypersensitivity Pneumonitis

GDF15 as a potential biomarker to distinguish fibrotic from non-fibrotic hypersensitivity pneumonitis

Mortality risk prediction with ILD-GAP index in a fibrotic hypersensitivity pneumonitis cohort

Lung Biopsy‐proved Hypersensitivity Pneumonitis Without Known Offending Antigen: Characteristics and Follow‐up

Chronic hypersensitivity pneumonitis: real world diagnostic criteria

High Prevalence of Pneumocystis Pneumonia in Interstitial Lung Disease: a Retrospective Study

Hypersensitivity Pneumonitis: An Interesting Case of Acute Shortness of Breath in a Young Patient

Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS/JRS/ALAT Clinical Practice Guideline

E064 Identifying patients with pulmonary disease in a mixed connective tissue disease cohort

Altered expression pattern of immune response-related genes and isoforms in hypersensitivity pneumonitis lung fibroblasts

Bronchoalveolar Lavage Fluid Cellular Analysis and Radiologic Patterns in Patients with Fibrotic Interstitial Lung Disease

Prevalence and risk factors of progressive pulmonary fibrosis(PPF) in patients with Interstitial Lung Disease(ILD) in a tertiary care center in India

Proteomic profiling of bronchoalveolar lavage fluid uncovers protein clusters linked to survival in idiopathic forms of interstitial lung disease

Idiopathic Pulmonary Fibrosis in the United Kingdom: Findings from the first decade of the largest single-country IPF Registry